Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-01-31 @ 11:20 PM
Study NCT ID:
NCT06940960
Status:
RECRUITING
Last Update Posted:
2025-06-10
First Post:
2025-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
Sponsor:
Affiliated Hospital of Guangdong Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
JY-CT-24-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None